|
2.00 Special
Senses and Speech
A. How do we evaluate
visual disorders?
1. What are visual
disorders? Visual disorders are abnormalities
of the eye, the optic nerve, the optic tracts, or the brain
that may cause a loss of visual acuity or visual fields.
A loss of visual acuity limits your ability to distinguish
detail, read, or do fine work. A loss of visual fields
limits your ability to perceive visual stimuli in the peripheral
extent of vision.
2. How do we define
statutory blindness? Statutory blindness is blindness
as defined in sections 216(i)(1) and 1614(a)(2) of the Social
Security Act (the Act). The Act defines blindness
as visual acuity of 20/200 or less in the better eye with
the use of a correcting lens. We use your best-corrected
visual acuity for distance in the better eye when we determine
if this definition is met. The Act also provides that
an eye that has a visual field limitation such that the
widest diameter of the visual field subtends an angle no
greater than 20 degrees is considered as having visual acuity
of 20/200 or less. You have statutory blindness only
if your visual disorder meets the criteria of 2.02 or 2.03A.
You do not have statutory blindness if your visual disorder
medically equals the criteria of 2.02 or 2.03A, or if it
meets or medically equals 2.03B, 2.03C, or 2.04. If
your visual disorder medically equals the criteria of 2.02
or 2.03A, or if it meets or medically equals 2.03B, 2.03C,
or 2.04, we will find that you have a disability if your
visual disorder also meets the duration requirement.
3. What evidence
do we need to establish statutory blindness under title
XVI? For title XVI, the only evidence we need
to establish statutory blindness is evidence showing that
your visual acuity in your better eye or your visual field
in your better eye meets the criteria in 2.00A2, provided
that those measurements are consistent with the other evidence
in your case record. We do not need to document the
cause of your blindness. Also, there is no duration
requirement for statutory blindness under title XVI (see
§§416.981 and 416.983).
4. What evidence
do we need to evaluate visual disorders, including those
that result in statutory blindness under title II?
a. To evaluate your
visual disorder, we usually need a report of an eye examination
that includes measurements of the best-corrected visual
acuity or the extent of the visual fields, as appropriate.
If there is a loss of visual acuity or visual fields, the
cause of the loss must be documented. A standard eye
examination will usually reveal the cause of any visual
acuity loss. An eye examination can also reveal the
cause of some types of visual field deficits. If the
eye examination does not reveal the cause of the visual
loss, we will request the information that was used to establish
the presence of the visual disorder.
b. A cortical visual
disorder is a disturbance of the posterior visual pathways
or occipital lobes of the brain in which the visual system
does not interpret what the eyes are seeing. It may
result from such causes as traumatic brain injury, stroke,
cardiac arrest, near drowning, a central nervous system
infection such as meningitis or encephalitis, a tumor, or
surgery. It can be temporary or permanent, and the
amount of visual loss can vary. It is possible to
have a cortical visual disorder and not have any abnormalities
observed in a standard eye examination. Therefore, a diagnosis
of a cortical visual disorder must be confirmed by documentation
of the cause of the brain lesion. If neuroimaging or visual
evoked response (VER) testing was performed, we will request
a copy of the report or other medical evidence that describes
the findings in the report.
c. If your visual
disorder does not satisfy the criteria in 2.02, 2.03, or
2.04, we will also request a description of how your visual
disorder impacts your ability to function.
5. How do we measure
best-corrected visual acuity?
a. Testing
for visual acuity. When we need to measure your best-corrected
visual acuity, we will use visual acuity testing that was
carried out using Snellen methodology or any other testing
methodology that is comparable to Snellen methodology.
b. Determining
best-corrected visual acuity.
(i) Best-corrected
visual acuity is the optimal visual acuity attainable with
the use of a corrective lens. In some instances, this assessment
may be performed using a specialized lens; for example,
a contact lens. We will use the visual acuity measurements
obtained with a specialized lens only if you have demonstrated
the ability to use the specialized lens on a sustained basis.
However, we will not use visual acuity measurements obtained
with telescopic lenses because they significantly reduce
the visual field. If you have an absent response to VER
testing in an eye, we can determine that your best-corrected
visual acuity is 20/200 or less in that eye. However, if
you have a positive response to VER testing in an eye, we
will not use that result to determine your best-corrected
visual acuity in that eye. Additionally, we will not use
the results of pinhole testing or automated refraction acuity
to determine your best-corrected visual acuity.
(ii) We will use the
best-corrected visual acuity for distance in your better
eye when we determine whether your loss of visual acuity
satisfies the criteria in 2.02. The best-corrected visual
acuity for distance is usually measured by determining what
you can see from 20 feet. If your visual acuity is measured
for a distance other than 20 feet, we will convert it to
a 20-foot measurement. For example, if your visual acuity
is measured at 10 feet and is reported as 10/40, we will
convert this to 20/80.
6. How do we measure
visual fields?
a. Testing for
visual fields.
(i) We generally need
visual field testing when you have a visual disorder that
could result in visual field loss, such as glaucoma, retinitis
pigmentosa, or optic neuropathy, or when you display behaviors
that suggest a visual field loss.
(ii)
When we need to measure the extent of your visual field
loss, we will use visual field measurements obtained with
an automated static threshold perimetry test performed on
a perimeter, like the Humphrey Field Analyzer, that satisfies
all of the following requirements:
A. The perimeter
must use optical projection to generate the test stimuli.
B. The perimeter
must have an internal normative database for automatically
comparing your performance with that of the general population.
C. The perimeter
must have a statistical analysis package that is able to
calculate visual field indices, particularly mean deviation.
D. The perimeter
must demonstrate the ability to correctly detect visual
field loss and correctly identify normal visual fields.
E. The perimeter
must demonstrate good test-retest reliability.
F. The perimeter
must have undergone clinical validation studies by three
or more independent laboratories with results published
in peer-reviewed ophthalmic journals.
(iii) The test must
use a white size III Goldmann stimulus and a 31.5 apostilb
(10 cd/m2) white background. The stimuli locations
must be no more than 6 degrees apart horizontally or vertically.
Measurements must be reported on standard charts and include
a description of the size and intensity of the test stimulus.
(iv) To determine
statutory blindness based on visual field loss (2.03A),
we need a test that measures the central 24 to 30 degrees
of the visual field; that is, the area measuring 24 to 30
degrees from the point of fixation. Acceptable tests include
the Humphrey 30-2 or 24-2 tests.
(v) The criterion
in 2.03B is based on the use of a test performed on a Humphrey
Field Analyzer that measures the central 30 degrees of the
visual field. We can also use comparable results from other
acceptable perimeters, for example, a mean defect of 22
on an acceptable Octopus test, to determine that the criterion
in 2.03B is met. We cannot use tests that do not measure
the central 30 degrees of the visual field, such as the
Humphrey 24-2 test, to determine if your impairment meets
or medically equals 2.03B.
(vi) We measure the
extent of visual field loss by determining the portion of
the visual field in which you can see a white III4e stimulus.
The “III” refers to the standard Goldmann test stimulus
size III, and the “4e” refers to the standard Goldmann intensity
filters used to determine the intensity of the stimulus.
(vii) In automated
static threshold perimetry, the intensity of the stimulus
varies. The intensity of the stimulus is expressed in decibels
(dB). We need to determine the dB level that corresponds
to a 4e intensity for the particular perimeter being used.
We will then use the dB printout to determine which points
would be seen at a 4e intensity level. For example, in Humphrey
Field Analyzers, a 10 dB stimulus is equivalent to a 4e
stimulus. A dB level that is higher than 10 represents a
dimmer stimulus, while a dB level that is lower than 10
represents a brighter stimulus. Therefore, for tests performed
on Humphrey Field Analyzers, any point seen at 10 dB or
higher is a point that would be seen with a 4e stimulus.
(viii) We can also
use visual field measurements obtained using kinetic perimetry,
such as the Humphrey “SSA Test Kinetic” or Goldmann perimetry,
instead of automated static threshold perimetry. The kinetic
test must use a white III4e stimulus projected on a white
31.5 apostilb (10 cd/m2) background. In automated
kinetic tests, such as the Humphrey “SSA Test Kinetic,”
testing along a meridian stops when you see the stimulus.
Because of this, automated kinetic testing does not detect
limitations in the central visual field. If your visual
disorder has progressed to the point at which it is likely
to result in a significant limitation in the central visual
field, such as a scotoma (see 2.00A8c), we will not use
automated kinetic perimetry to evaluate your visual field
loss. Instead, we will assess your visual field loss using
automated static threshold perimetry or manual kinetic perimetry.
(ix) We will not use
the results of visual field screening tests, such as confrontation
tests, tangent screen tests, or automated static screening
tests, to determine that your impairment meets or medically
equals a listing or to evaluate your residual functional
capacity. However, we can consider normal results from visual
field screening tests to determine whether your visual disorder
is severe when these test results are consistent with the
other evidence in your case record. (See §§404.1520(c),
404.1521, 416.920(c), and 416.921.) We will not consider
normal test results to be consistent with the other evidence
if either of the following applies:
A. The clinical
findings indicate that your visual disorder has progressed
to the point that it is likely to cause visual field loss,
or
B. You have
a history of an operative procedure for retinal detachment.
b. Use of corrective
lenses. You must not weareyeglasses during the visual
field examination because they limit your field of vision.
Contact lenses or perimetric lenses may be used to correct
visual acuity during the visual field examination in order
to obtain the most accurate visual field measurements. For
this single purpose, you do not need to demonstrate that
you have the ability to use the contact or perimetric lenses
on a sustained basis.
7. How do we calculate
visual efficiency?
a. Visual
acuity efficiency. We use the percentage shown in Table
1 that corresponds to the best-corrected visual acuity for
distance in your better eye.
b. Visual field
efficiency. We use kinetic perimetry to calculate visual
field efficiency by adding the number of degrees seen along
the eight principal meridians in your better eye and dividing
by 500. (See Table 2.)
c. Visual
efficiency. We calculate the percent of visual efficiency
by multiplying the visual acuity efficiency by the visual
field efficiency and converting the decimal to a percentage.
For example, if your visual acuity efficiency is 75 percent
and your visual field efficiency is 64 percent, we will
multiply 0.75 x 0.64 to determine that your visual efficiency
is 0.48, or 48 percent.
8. How
do we evaluate specific visual problems?
a. Statutory blindness.
Most test charts that use Snellen methodology do not have
lines that measure visual acuity between 20/100 and 20/200.
Newer test charts, such as the Bailey-Lovie or the Early
Treatment Diabetic Retinopathy Study (ETDRS), do have lines
that measure visual acuity between 20/100 and 20/200. If
your visual acuity is measured with one of these newer charts,
and you cannot read any of the letters on the 20/100 line,
we will determine that you have statutory blindness based
on a visual acuity of 20/200 or less. For
example, if your best-corrected visual acuity for distance
in the better eye was determined to be 20/160 using an ETDRS
chart, we will find that you have statutory blindness. Regardless
of the type of test chart used, you do not have statutory
blindness if you can read at least one letter on the 20/100
line. For example, if your best-corrected visual acuity
for distance in the better eye was determined to be 20/125+1
using an ETDRS chart, we will find that you do not have
statutory blindness as you are able to read one letter on
the 20/100 line.
b. Blepharospasm.
This movement disorder is characterized by repetitive, bilateral,
involuntary closure of the eyelids. If you have this disorder,
you may have measurable visual acuities and visual fields
that do not satisfy the criteria of 2.02 or 2.03. Blepharospasm
generally responds to therapy. However, if therapy is not
effective, we will consider how the involuntary closure
of your eyelids affects your ability to maintain visual
functioning over time.
c. Scotoma.
A scotoma is a non-seeing area in the visual field surrounded
by a seeing area. When we measure the visual field, we subtract
the length of any scotoma, other than the normal blind spot,
from the overall length of any diameter on which it falls.
B. Otolaryngology
1. Hearing Impairment.
Hearing ability should be evaluated in terms of the
person's ability to hear and distinguish speech.
Loss of hearing can
be quantitatively determined by an audiometer which meets
the standards of the American National Standards Institute
(ANSI) for air and bone conducted stimuli (i.e., ANSI S
3.6‑1969 and ANSI S 3.13-1972, or subsequent comparable
revisions) and performing all hearing measurements in an
environment which meets the ANSI standard for maximal permissible
background sound (ANSI S 3.1‑1977).
Speech discrimination
should be determined using a standardized measure of speech
discrimination ability in quiet at a test presentation level
sufficient to ascertain maximum discrimination ability.
The speech discrimination measure (test) used, and the level
at which testing was done must be reported.
Hearing tests should
be preceded by an otolaryngologic examination and should
be performed by or under the supervision of an otolaryngologist
or audiologist qualified to perform such tests.
In order to establish
an independent medical judgment as to the level of impairment
in a claimant alleging deafness, the following examinations
should be reported: Otolaryngologic examination, pure tone
air and bone audiometry, speech reception threshold (SRT),
and speech discrimination testing. A copy of reports of
medical examination and audiologic evaluations must be submitted.
Cases
of alleged "deaf mutism" should be documented by a hearing
evaluation. Records obtained from a speech and hearing rehabilitation
center or a special school for the deaf may be acceptable,
but if these reports are not available, or are found to
be inadequate, a current hearing evaluation should be submitted
as outlined in the preceding paragraph.
2. Vertigo associated
with disturbances of labyrinthine‑vestibular function,
including Meniere's disease. These disturbances of
balance are characterized by an hallucination of motion
or a loss of position sense and a sensation of dizziness
which may be constant or may occur in paroxysmal attacks.
Nausea, vomiting, ataxia, and incapacitation are frequently
observed, particularly during the acute attack. It is important
to differentiate the report of rotary vertigo from that
of "dizziness" which is described as light‑headedness,
unsteadiness, confusion, or syncope.
Meniere's disease
is characterized by paroxysmal attacks of vertigo, tinnitus,
and fluctuating hearing loss. Remissions are unpredictable
and irregular, but may be long-lasting; hence, the severity
of impairment is best determined after prolonged observation
and serial reexaminations.
The diagnosis of a
vestibular disorder requires a comprehensive neuro-otolaryngologic
examination with a detailed description of the vertiginous
episodes, including notation of frequency, severity, and
duration of the attacks. Pure tone and speech audiometry
with the appropriate special examinations, such as Bekesy
audiometry, are necessary. Vestibular function is accessed
by positional and caloric testing, preferably by electronystagmography.
When polytomograms, contrast radiography, or other special
tests have been performed, copies of the reports of these
tests should be obtained in addition to appropriate medically
acceptable imaging reports of the skull and temporal bone.
Medically acceptable imaging includes, but is not limited
to, x-ray imaging, computerized axial tomography (CAT scan)
or magnetic resonance imaging (MRI), with or without contrast
material, myelography, and radiocnuclear bone scans.
“Appropriate” means that the technique used is the proper
one to support the evaluation and diagnosis of the impairment.
3. Loss of speech.
In evaluating the loss of speech, the ability to produce
speech by any means includes the use of mechanical or electronic
devices that improve voice or articulation. Impairments
of speech may also be evaluated under the body system for
the underlying disorder, such as neurological disorders,
11.00ff.
C. How do
we evaluate impairments that do not meet one of the special
senses and speech listings?
1. These listings
are only examples of common special senses and speech disorders
that we consider severe enough to prevent an individual
from doing any gainful activity. If your impairment(s)
does not meet the criteria of any of these listings, we
must also consider whether you have an impairment(s) that
satisfies the criteria of a listing in another body system.
2. If you have a medically
determinable impairment(s) that does not meet a listing,
we will determine whether the impairment(s) medically equals
a listing. (See §§404.1526 and 416.926.) If
you have an impairment(s) that does not meet or medically
equal a listing, you may or may not have the residual functional
capacity to engage in substantial gainful activity.
Therefore, we proceed to the fourth, and if necessary, the
fifth steps of the sequential evaluation process in §§404.1520
and 416.920. When we decide whether you continue to
be disabled, we use the rules in §§404.1594, 416.994, or
416.994a, as appropriate.
2.01
Category of Impairments, Special Senses and Speech
2.02
Loss of Visual Acuity.
Remaining vision in the better eye after
best correction is 20/200 or less.
2.03
Contraction of the visual field in
the better eye, with:
A. The widest
diameter subtending an angle around the point of fixation
no greater than 20 degrees;
OR
B. A mean deviation
of –22 or worse, determined by automated static threshold
perimetry as described in 2.00A6a (v);
OR
C. A visual
field efficiency of 20 percent or less as determined by
kinetic perimetry (see 2.00A7b).
2.04
Loss of visual efficiency.
Visual efficiency of the better eye of 20 percent or less
after best correction (see 2.00A7c).
2.07
Disturbance of labyrinthine‑vestibular function
(Including Meniere's disease), characterized by a history
of frequent attacks of balance disturbance, tinnitus, and
progressive loss of hearing. With both A and B:
A. Disturbed
function of vestibular labyrinth demonstrated by caloric
or other vestibular tests; and
B. Hearing loss
established by audiometry.
2.08
Hearing Impairments (hearing
not restorable by a hearing aid) manifested by:
A. Average hearing
threshold sensitivity for air conduction of 90 decibels
or greater, and for bone conduction to corresponding maximal
levels, in the better ear, determined by the simple average
of hearing threshold levels at 500, 1000, and 2000hz. (see
2.00B1); or
B. Speech discrimination
scores of 40 percent or less in the better ear.
2.09
Loss of speech due to any cause, with inability
to produce by any means speech that can be heard, understood,
or
sustained.
Table 1
– Percentage of Visual Acuity Efficiency Corresponding to
the Best-Corrected Visual Acuity Measurement for
Distance in the Better Eye
|
Snellen
|
Percent visual acuity
efficiency
|
|
English
|
Metric
|
|
|
20/16
|
6/5
|
100
|
|
20/20
|
6/6
|
100
|
|
20/25
|
6/7.5
|
95
|
|
20/30
|
6/9
|
90
|
|
20/40
|
6/12
|
85
|
|
20/50
|
6/15
|
75
|
|
20/60
|
6/18
|
70
|
|
20/70
|
6/21
|
65
|
|
20/80
|
6/24
|
60
|
|
20/100
|
6/30
|
50
|
Table No.
2. - Chart of Visual Fields
|
Left Eye (O.S.)
|
Right Eye (O.D.)
|
1. The diagram of
the right eye illustrates the extent of a normal visual
field as measured with a III4e stimulus. The sum of
the eight principal meridians of this field is 500 degrees.
2. The
diagram of the left eye illustrates a visual field contracted
to 30 degrees in two meridians and to 20 degrees in the
remaining six meridians. The percent of visual field efficiency
of this field is: (2 x 30) + (6 x 20) = 180 ÷ 500 = 0.36
or 36 percent visual field efficiency.
|